Implantable pressure sensor market forecast to reach $7.37 billion by 2030

By AI, Created 5:13 PM UTC, May 18, 2026, /AGP/ – The implantable pressure sensor market is projected to rise from $4.22 billion in 2025 to $4.71 billion in 2026, then reach $7.37 billion by 2030, according to The Business Research Company. Growth is being driven by cardiovascular disease cases, remote monitoring demand and broader adoption of digital health tools.

Why it matters: - Implantable pressure sensors support continuous internal monitoring for patients with chronic heart and blood vessel conditions. - The market’s growth tracks broader demand for remote patient monitoring, personalized care and minimally invasive procedures. - Cardiovascular disease remains a major demand driver, with pressure sensors helping clinicians track intracardiac or arterial pressure over time.

What happened: - The Business Research Company released its Implantable Pressure Sensor Global Market Report 2026, covering market size, trends and forecasts through 2035. - The report estimates the market will grow from $4.22 billion in 2025 to $4.71 billion in 2026. - The report projects the market will reach $7.37 billion by 2030. - The forecast period implies an 11.8% compound annual growth rate through 2030. - The company published the report on May 15, 2026.

The details: - Implantable pressure sensors are medical devices placed inside the body to measure pressure in organs or blood vessels. - The sensors convert physiological pressure into electrical signals for clinical or research use. - The technology supports real-time data collection for diagnosis, monitoring and treatment decisions. - Growth drivers include rising cardiovascular disease incidence, stronger demand for continuous patient monitoring, advances in MEMS technology, more minimally invasive surgeries and expanding healthcare infrastructure. - Longer-term growth is expected to come from remote patient monitoring systems, deeper integration with digital health platforms, personalized treatment needs, an aging population and more R&D spending on implantable medical devices. - The report identifies wireless implantable sensors, continuous real-time internal monitoring, device miniaturization, minimally invasive implantation techniques and new cardiovascular and neurological uses as key trends. - North America was the largest regional market in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The regional analysis also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - A sample report is available here. - The full report is available here.

Between the lines: - The forecast suggests implantable pressure sensors are moving from niche clinical tools toward broader use in connected care workflows. - The strongest demand signal is the need to monitor high-risk patients outside traditional hospital settings. - The regional split points to mature adoption in North America and faster expansion opportunities in Asia-Pacific. - CDC data cited in the release shows cardiovascular disease caused 919,032 deaths in the US in October 2024, about one in three deaths. - The same CDC data shows about 805,000 heart attacks, including 605,000 first-time events and 200,000 repeat cases.

What’s next: - Market growth is likely to stay tied to digital health adoption, clinical use of wireless sensors and broader deployment of minimally invasive implants. - Manufacturers and healthcare providers are likely to focus on real-time monitoring capabilities and smaller devices that are easier to implant. - Further growth will depend on how quickly hospitals and device makers translate R&D into commercial and clinical adoption.

The bottom line: - Implantable pressure sensors are set for steady double-digit growth as cardiovascular monitoring, remote care and digital health integration become more central to treatment.